Eli Lilly just gave investors several reasons to cheer.

Blockbuster weight-loss drugs can help to stop and reverse the global obesity crisis, experts from the World Health ...

Popular brands on the market also include Ozempic’s sister drug Wegovy and Eli Lilly’s (LLY-0.02%) Zepbound. Soaring demand ...

At the time the deal was announced, Novo Nordisk (DK:NOVO.B), the maker of diabetes drugs Wegovy and others, said it was "aligned" with its strategy of reaching more people living with diabetes and ...

Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

Merck & Co. has secured a licensing agreement with Chinese drugmaker Hansoh Pharma for an experimental oral weight-loss drug, ...

Novo Holdings, the controlling shareholder of Novo Nordisk, on Wednesday sealed its $16.5 billion deal for Catalent, as the ...

Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have ...

A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity ...